Estrogen receptor α and β expression in a case matched series of serous and endometrioid adenocarcinomas of the ovary

European Journal of Gynaecological Oncology

Volumn 29, Issue 2, 2008, Pages 126-128

  Geisler, J P ^a   Buller, E ^b   Manahan, K J ^b  

^a Indiana Women's Oncology PC   (United States)

^b NONE

Author keywords

Endometrioid; Estrogen receptor; Methylation; Ovarian cancer; Serous

Indexed keywords

COMPLEMENTARY DNA; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA;

ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; CYSTADENOCARCINOMA; ENDOMETRIOID CARCINOMA; FEMALE; GENE AMPLIFICATION; HOUSEKEEPING GENE; HUMAN; OVARY ADENOCARCINOMA; PROTEIN EXPRESSION; PROTEIN METHYLATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CARCINOMA, ENDOMETRIOID; CASE-CONTROL STUDIES; CPG ISLANDS; CYSTADENOCARCINOMA, SEROUS; DNA METHYLATION; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; NEOPLASM STAGING; OVARIAN NEOPLASMS; RNA, MESSENGER;

EID: 41849136194     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., Thun M. J.: "Cancer Statistics 2003". CA Cancer J. Clin., 2003, 53, 5.
2. Zwart J., Geisler J.P., Geisler H.E.: "Five-year survival in patients with endometrioid carcinoma of the ovary versus those with serous carcinoma". Eur. J. Gynaecol. Oncol., 1998, 19, 225.
3. Tammela J., Geisler J.P., Eskew P.N., Jr., Geisler H.E.: "Clear cell carcinoma of the ovary: poor prognosis compared to serous carcinoma". Eur. J. Gynaecol. Oncol., 1998, 19, 438.
4. Hilton J.L., Geisler J.P., Rathe J.A., Hattermann-Zogg M.A., De Young B., Buller R.E.: "Inactivation of BRCA1 and BRCA2 in ovarian cancer". J. Natl. Cancer Inst., 2002, 94, 1396.
5. Shigemasa K., Tian X, Gu L., Shiroyama Y., Nagai N., Ohama K.: "Expression of cyclooxygenase-2 and its relationship to p53 accumulation in ovarian adenocarcinomas". Int. J. Oncol., 2003, 22, 99.
6. Geisler J.P., Geisler H.E., Miller G.A., Wiemann M.C., Zhou W., Crabtree W.: "p53 and bc1-2 in epithelial ovarian carcinoma: their value as prognostic indicators at a median of 60 months of follow-up". Gynecol. Oncol., 2000, 77, 278.
7. Geisler J.P., Geisler H.E., Miller G.A., Weimann M.C., Zhou W., Miller J., Crabtree W.: "Stratification of patients with epithelial ovarian carcinoma into high and low risk categories". CME J. Gynecol. Oncol., 2000, 5, 231.
8. Skilling J.S., Sood A.K., Niemann T., Lager D.J., Buller R.E.: "An abundance of p53 null mutations in ovarian cancer". Oncogene, 1996, 13, 117.
9. Rutherford T., Brown W.D., Sapi E., Aschkenazi S., Munoz A., Mor G.: "Absence of estrogen receptor-b expression in metastatic ovarian cancer". Obstet. Gynecol., 2000, 96, 417.
10. Esteller M., Silva J.M., Dominguez G., Bonilla F., Matias-Guiu X, Lerma E. et al.: "Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors". J. Natl. Cancer Inst., 2000, 92, 564.
11. Geisler J.P., Hatterman-Zogg M.A., Rathe J.A., Buller R.E.: "BRCA1 dysfunction is common in ovarian cancer". J. Natl. Cancer Inst., 2002, 94, 61.
12. Clark S.J., Harrison J., Paul C.L., Frommer M.: "High sensitivity mapping of methylated cytosines". Nuc. Acid Res., 1994, 22, 2990.
13. Herman J.G., Graff J., Myohanen S., Nelkin B.D., Baylin S.B.: "Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands". Proc. Natl. Acad. Sci. USA, 1996, 93, 9821.
14. Domann F.E., Rice J.C., Hendrix M.J.C., Futscher B.W.: "Epigenetic silencing of maspin gene expression in human breast cancers". Int. J. Cancer, 2000, 85, 805.
15. Sasaki M., Kotcherguina L., Dharia A., Fujimoto S., Dahiya R.: "Cytosine-phosphoguanine methylation of estrogen receptors in endometrial cancer". Cancer Res., 2001, 61, 3262.
16. Li L.C., Dahiya R.: "MethPrimer: designing primers for methylation PCRs". Bioinformatics, 2002, 18, 1427.
17. Shiozawa T., Itoh K., Horiuchi A., Konishi I., Fujii S., Nikaido T.: "Down-regulation of estrogen receptor by the methylation of the estrogen receptor gene in endometrial carcinoma". Anticancer, 2002, 22, 139.
18. Maeda K., Tsuda H., Hashiguchi Y., Yamamoto K., Inoue T., Ishiko O., Ogita S.: "Relationship between p53 pathway and estrogen receptor status in endometrioid-type endometrial cancer". Hum. Pathol., 2002, 33, 386.
19. O'Doherty A.M., Church S.W., Russell S.E., Nelson J., Hickey I.: "Methylation status of oestrogen receptor-alpha gene promoter sequences in human ovarian epithelial cell lines". Br. J. Cancer, 2002, 86, 282.
20. Geisler J.P., Hatterman-Zogg M.A., Rathe J.A., Buller R.E.: "BRCA1 dysfunction is common in ovarian cancer". J. Natl. Cancer Inst., 2002, 94, 61.
21. Geisler J.P., Sood A.K., Holmes R.J., Hatterman-Zogg M.A., Rathe J.A., Buller R.E.: "Mismatch repair gene expression defects contribute to microsatellite instability in ovarian cancer". Cancer, 2003, 98, 2199.
22. Geisler J.P., Buller R.E.: "Mismatch repair gene expression defects contribute to microsatellite instability in ovarian cancer". Cancer, 2004, 1000, 2486.
23. Li A.J., Baldwin R.L., Karlan B.Y.: "Estrogen and progesterone receptor subtype expression in normal and malignant epithelial ovarian cell cultures". Am. J. Obstet. Gynecol., 2003, 189, 22.
24. Geisler J.P., Geisler H.E., Wiemann M.C., Givens S.S., Zhou Z., Miller G.A.: "Quantification of p53 in epithelial ovarian cancer". Gynecol. Oncol., 1997, 66, 435.
25. Geisler J.P., Wiemann M.C., Miller G.A., Geisler H.E.: "Estrogen and progesterone receptor status as prognostic indicators in patients with optimally cytoreduced stage IIIc serous cystadenocarcinoma of the ovary". Gynecol. Oncol., 1996, 60, 424.